Erez Marcusohn
Overview
Explore the profile of Erez Marcusohn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
199
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marcusohn E, Manoragavan R, Fremes S, Tarola C, Sathananthan J, Barabash I, et al.
BMC Cardiovasc Disord
. 2024 Aug;
24(1):422.
PMID: 39135174
Background: Despite impressive improvements in the safety profile of Transcatheter aortic valve replacement (TAVR), the risk for peri-procedural stroke after TAVR has not declined substantially. In an effort to reduce...
2.
Qasum M, Massalha S, Marcusohn E, Elias A, Darawshi S, Zukermann R
Am Heart J Plus
. 2024 Mar;
27:100276.
PMID: 38511099
Aims CCTA is a well-established and safe imaging modality for the diagnosis of CAD and is gate keeping for invasive coronary angiography (ICA). We aimed to examine CCTA performance in...
3.
Savren Lotker J, Roguin A, Kerner A, Marcusohn E, Kobo O
Isr Med Assoc J
. 2024 Mar;
26(3):162-168.
PMID: 38493327
Background: Patients with inflammatory bowel disease (IBD) are at increased risk after percutaneous coronary intervention (PCI). Objectives: To compare the clinical outcomes within 30 days, one year, and five years...
4.
Marcusohn E, Tobe S, Dueck A, Madan M
CMAJ
. 2024 Feb;
196(4):E136-E141.
PMID: 38316459
No abstract available.
5.
Volis I, Postnikov M, Reiner-Benaim A, Hellman Y, Marcusohn E
J Cardiovasc Med (Hagerstown)
. 2024 Jan;
25(3):193-199.
PMID: 38251452
Aims: Angiotensin receptor neprilysin inhibitor (ARNI) therapy is a cornerstone in the treatment of heart failure with reduced ejection fraction (HFrEF), with significant improvement in mortality as well as morbidity...
6.
Bar O, Elias A, Halhal B, Marcusohn E
J Cardiovasc Med (Hagerstown)
. 2023 Dec;
25(2):104-113.
PMID: 38064345
Aims: Current guidelines recommend an early (<24 h) invasive coronary angiography (ICA) strategy in non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients with Global Registry of Acute Coronary Events (GRACE) score...
7.
Bloch-Isenberg N, Zukermann R, Massalha S, Qasum M, Reiner Benaim A, Marcusohn E
J Cardiovasc Med (Hagerstown)
. 2023 Dec;
25(1):63-67.
PMID: 38051642
Background: Transesophageal echocardiography (TEE) is the gold standard test for the diagnosis of left atrial appendage (LAA) thrombus. Nonetheless, computerized tomography angiography (CTA) is readily used to exclude LAA thrombus...
8.
Marcusohn E, Tobe S, Dueck A, Madan M
CMAJ
. 2023 Nov;
195(43):E1475-E1480.
PMID: 37931951
No abstract available.
9.
Korytny A, Mazzawi F, Marcusohn E, Klein A, Epstein D
Eur Surg Res
. 2023 Oct;
64(4):398-405.
PMID: 37812930
Introduction: Calcium is an essential co-factor in the coagulation cascade, and hypocalcemia is associated with adverse outcomes in bleeding patients, including trauma patients, women with postpartum hemorrhage, and patients with...
10.
Marcusohn E, Barbara A, Epstein D, Massalha S, Zukermann R
J Cardiovasc Med (Hagerstown)
. 2023 Apr;
24(6):334-339.
PMID: 37115968
Purpose: To assess the correlation between high sensitive troponin I (HsTnI) levels and myocardial damage on cardiac magnetic resonance (CMR) represented by late gadolinium enhancement (LGE) percentage in patients diagnosed...